HUMA

Humacyte, Inc.

4.39 USD
-0.14 (-3.09%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Humacyte, Inc. stock is up 37.62% since 30 days ago. The next earnings date is Mar 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 3 February’s closed higher than January.

About Humacyte, Inc.

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues. Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company was founded in 2004 and is headquartered in Durham, North Carolina.